Trial intelligence / Profile preview

Tranexamic acid for bleeding control during rhinoplasty

IRCT20141009019470N109Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in intraoperative bleeding (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Intraoperative bleeding, Postoperative bleeding and 2 more. Started Feb 2021; status: completed.

02

Drugs

tranexamic acid
03

Conditions

intraoperative bleeding

Beyond the preview

Go deeper on IRCT20141009019470N109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141009019470N109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call